W

Whanin Pharm Co Ltd
KRX:016580

Watchlist Manager
Whanin Pharm Co Ltd
KRX:016580
Watchlist
Price: 11 640 KRW 0.26% Market Closed
Market Cap: 177.7B KRW

Intrinsic Value

The intrinsic value of one Whanin Pharm Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 11 640 KRW, Whanin Pharm Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Whanin Pharm Co Ltd Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Whanin Pharm Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Whanin Pharm Co Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Whanin Pharm Co Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Whanin Pharm Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Whanin Pharm Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Whanin Pharm Co Ltd.

Explain Valuation
Compare Whanin Pharm Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Whanin Pharm Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Whanin Pharm Co Ltd

Current Assets 205.2B
Cash & Short-Term Investments 45.8B
Receivables 71.1B
Other Current Assets 88.3B
Non-Current Assets 224.5B
Long-Term Investments 63.5B
PP&E 146.8B
Intangibles 9.9B
Other Non-Current Assets 4.4B
Current Liabilities 41.8B
Accounts Payable 22.8B
Accrued Liabilities 5.1B
Other Current Liabilities 14B
Non-Current Liabilities 7.4B
Long-Term Debt 398.7m
Other Non-Current Liabilities 7B
Efficiency

Free Cash Flow Analysis
Whanin Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Whanin Pharm Co Ltd

Revenue
258.7B KRW
Cost of Revenue
-172.4B KRW
Gross Profit
86.3B KRW
Operating Expenses
-72.1B KRW
Operating Income
14.2B KRW
Other Expenses
2.2B KRW
Net Income
16.4B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Whanin Pharm Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Sustainable 3Y Average Gross Margin
Healthy Gross Margin
Sustainable 3Y Average Operating Margin
Sustainable 3Y Average Net Margin
hidden
Profitability
Score

Whanin Pharm Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Whanin Pharm Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

Whanin Pharm Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Whanin Pharm Co Ltd

Wall Street analysts forecast Whanin Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Whanin Pharm Co Ltd is 14 280 KRW with a low forecast of 14 140 KRW and a high forecast of 14 700 KRW.

Lowest
Price Target
14 140 KRW
21% Upside
Average
Price Target
14 280 KRW
23% Upside
Highest
Price Target
14 700 KRW
26% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Whanin Pharm Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Whanin Pharm Co Ltd stock?

The intrinsic value of one Whanin Pharm Co Ltd stock under the Base Case scenario is hidden KRW.

Is Whanin Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 11 640 KRW, Whanin Pharm Co Ltd is hidden .

Back to Top